The targets of 111 putative therapeutic targets in the treatment of PCOS include AKT1, IL-6, VEGFA, CCND1, STAT3, MAPK1, MAPK8, ESR1, FN1, MMP9, CXCL8, MAPK14, AR, PPARG, and HIF1A. Here, PPARG is linked to polycystic ovary syndrome.